S
012790
vs
MRK
MRK
Over the past 12 months, Sinil Pharmaceutical Co Ltd has underperformed MRK, delivering a return of -6% compared to the MRK's +53% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
MRK
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
S
|
Sinil Pharmaceutical Co Ltd
KOSDAQ:012790
|
6 040
KRW
|
|||||
|
Merck & Co Inc
NYSE:MRK
|
121.42
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
012790, MRK
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
S
|
Sinil Pharmaceutical Co Ltd
Revenue
|
|||||||||||
|
|
Merck & Co Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
012790, MRK
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
S
|
Sinil Pharmaceutical Co Ltd
KOSDAQ:012790
|
|||||||||
|
|
Merck & Co Inc
NYSE:MRK
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sinil Pharmaceutical Co Ltd | ||||
|
|
Merck & Co Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sinil Pharmaceutical Co Ltd | ||||
|
|
Merck & Co Inc | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sinil Pharmaceutical Co Ltd | ||||
|
|
Merck & Co Inc | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sinil Pharmaceutical Co Ltd | ||||
|
|
Merck & Co Inc | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sinil Pharmaceutical Co Ltd | ||||
|
|
Merck & Co Inc | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sinil Pharmaceutical Co Ltd | ||||
|
|
Merck & Co Inc | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sinil Pharmaceutical Co Ltd | ||||
|
|
Merck & Co Inc | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Sinil Pharmaceutical Co Ltd | ||||
|
|
Merck & Co Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
012790, MRK
Performance By Year
012790, MRK
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
